GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citius Oncology Inc (NAS:CTOR) » Definitions » FCF Yield %

CTOR (Citius Oncology) FCF Yield % : -9.87 (As of Apr. 05, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Citius Oncology FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Citius Oncology's Trailing 12-Month Free Cash Flow is $-4.87 Mil, and Market Cap is $49.38 Mil. Therefore, Citius Oncology's FCF Yield % for today is -9.87%.

The historical rank and industry rank for Citius Oncology's FCF Yield % or its related term are showing as below:

CTOR' s FCF Yield % Range Over the Past 10 Years
Min: -10.04   Med: 0   Max: 0
Current: -9.87

CTOR's FCF Yield % is ranked worse than
77.99% of 1027 companies
in the Drug Manufacturers industry
Industry Median: 0.1 vs CTOR: -9.87

Citius Oncology's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

Citius Oncology FCF Yield % Historical Data

The historical data trend for Citius Oncology's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Citius Oncology FCF Yield % Chart

Citius Oncology Annual Data
Trend Sep22 Sep23 Sep24
FCF Yield %
- - -4.90

Citius Oncology Semi-Annual Data
Sep22 Sep23 Sep24
FCF Yield % - - -4.90

Competitive Comparison of Citius Oncology's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Citius Oncology's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Citius Oncology's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Citius Oncology's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Citius Oncology's FCF Yield % falls into.


;
;

Citius Oncology FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Citius Oncology's FCF Yield % for the fiscal year that ended in Sep. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-4.874 / 99.45728
=-4.90%

Citius Oncology's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-4.874 * 1 / 99.45728
=-4.90%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Citius Oncology FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Citius Oncology FCF Yield % Related Terms

Thank you for viewing the detailed overview of Citius Oncology's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Citius Oncology Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citius Oncology Inc (NAS:CTOR) » Definitions » FCF Yield %
Comparable Companies
SCYX RMTI SXTC MRMD ETST CPIX ASRT INCR INIS DRRX ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
N/A
Address
11 Commerce Drive, First Floor, Cranford, NY, USA, 07016
Website
https://www.citiusonc.com
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.